|
C14ORF138 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.059900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.025800E-02 |
| Normal-vs-Stage2 |
4.082800E-01 |
| Normal-vs-Stage3 |
4.443800E-02 |
| Normal-vs-Stage4 |
2.845200E-01 |
| Stage1-vs-Stage2 |
7.018000E-01 |
| Stage1-vs-Stage3 |
5.554800E-01 |
| Stage1-vs-Stage4 |
6.650200E-01 |
| Stage2-vs-Stage3 |
4.880600E-01 |
| Stage2-vs-Stage4 |
9.863800E-01 |
| Stage3-vs-Stage4 |
3.995400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.115610E-01 |
| Normal-vs-AfricanAmerican |
1.342470E-03 |
| Normal-vs-Asian |
1.868830E-01 |
| Caucasian-vs-AfricanAmerican |
7.120800E-03 |
| Caucasian-vs-Asian |
2.455800E-01 |
| AfricanAmerican-vs-Asian |
5.342400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.136200E-01 |
| Normal-vs-Female |
1.170020E-04 |
| Male-vs-Female |
4.374200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.950400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.752300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.250300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.554200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.212400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.680400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.362000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.445000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.828800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.661200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.217600E-02 |
| Normal-vs-Grade 2 |
2.282500E-03 |
| Normal-vs-Grade 3 |
1.773240E-01 |
| Normal-vs-Grade 4 |
8.336400E-01 |
| Grade 1-vs-Grade 2 |
4.982200E-01 |
| Grade 1-vs-Grade 3 |
1.008980E-01 |
| Grade 1-vs-Grade 4 |
6.849600E-02 |
| Grade 2-vs-Grade 3 |
1.029780E-01 |
| Grade 2-vs-Grade 4 |
8.262000E-03 |
| Grade 3-vs-Grade 4 |
1.992600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.900830E-03 |
| Normal-vs-ccB subtype |
8.519000E-01 |
| ccA subtype-vs-ccB subtype |
9.403700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.621700E-02 |
| Normal-vs-N1 |
4.000400E-01 |
| N0-vs-N1 |
1.443240E-01 |
|
|
